Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP513536.RAZBNl2rwIBVFQX3U8rwl1TvYjt_LNqaujzoew3DQlO7s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP513536.RAZBNl2rwIBVFQX3U8rwl1TvYjt_LNqaujzoew3DQlO7s130_assertion type Assertion NP513536.RAZBNl2rwIBVFQX3U8rwl1TvYjt_LNqaujzoew3DQlO7s130_head.
- NP513536.RAZBNl2rwIBVFQX3U8rwl1TvYjt_LNqaujzoew3DQlO7s130_assertion description "[We selected the 10 most promising genes, according to their capability when down-regulated or up-regulated in ALS animal models, for increasing life span and mitigating disease progression: XBP-1, NogoA and NogoB, dynein, heavy and medium neurofilament, NOX1 and NOX2, MLC-mIGF-1, NSE-VEGF, and MMP-9.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP513536.RAZBNl2rwIBVFQX3U8rwl1TvYjt_LNqaujzoew3DQlO7s130_provenance.
- NP513536.RAZBNl2rwIBVFQX3U8rwl1TvYjt_LNqaujzoew3DQlO7s130_assertion evidence source_evidence_literature NP513536.RAZBNl2rwIBVFQX3U8rwl1TvYjt_LNqaujzoew3DQlO7s130_provenance.
- NP513536.RAZBNl2rwIBVFQX3U8rwl1TvYjt_LNqaujzoew3DQlO7s130_assertion SIO_000772 21816207 NP513536.RAZBNl2rwIBVFQX3U8rwl1TvYjt_LNqaujzoew3DQlO7s130_provenance.
- NP513536.RAZBNl2rwIBVFQX3U8rwl1TvYjt_LNqaujzoew3DQlO7s130_assertion wasDerivedFrom befree-20140225 NP513536.RAZBNl2rwIBVFQX3U8rwl1TvYjt_LNqaujzoew3DQlO7s130_provenance.
- NP513536.RAZBNl2rwIBVFQX3U8rwl1TvYjt_LNqaujzoew3DQlO7s130_assertion wasGeneratedBy ECO_0000203 NP513536.RAZBNl2rwIBVFQX3U8rwl1TvYjt_LNqaujzoew3DQlO7s130_provenance.